- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imageon completes financing, appoints new CEO
Imageon completes financing, appoints new CEOImageon Solutions closed its first round of major financing last month, which should further the company’s efforts to develop Internet-based clinical image management networks. Emerging
Imageon completes financing, appoints new CEO
Imageon Solutions closed its first round of major financing last month, which should further the companys efforts to develop Internet-based clinical image management networks. Emerging Technology Partners of Birmingham, AL, led the round, which concluded Jan. 10 and included Paradigm Venture Partners, Finn Partners, and other private investors.
Imageon, also of Birmingham, plans to use the funds to expand its sales and marketing structure and to seek alliances with OEMs and HIS/RIS vendors. The amount raised was not disclosed.
Also last month, the company named Charles Jett to the post of chairman and CEO, and Jeff Timbrook to the position of vice president of sales and marketing. Jett joined Imageon from Walker Interactive Systems, where he served as vice president and general manager of the companys Immpower division. Timbrook comes to his post with 15 years of healthcare information technology sales and marketing experience, and has served as vice president of sales and marketing for StorCOMM.
© 2000 Miller Freeman, Inc., a United News & Media company
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
